Margaret Alexander, Vaibhav Upadhyay, Rachel Rock, Lorenzo Ramirez, Kai Trepka, Patrycja Puchalska, Diego Orellana, Qi Yan Ang, Caroline Whitty, Jessie A. Turnbaugh, Yuan Tian, Darren Dumlao, Renuka Nayak, Andrew Patterson, John C. Newman, Peter A. Crawford, and Peter J. Turnbaugh

New research highlights the powerful connection between ketogenic diets (KDs), the gut microbiota, and immune regulation. This study shows that KDs—high-fat, low-carbohydrate diets—can protect against autoimmune conditions like multiple sclerosis (MS) by altering gut bacteria. A key player is beta-hydroxybutyrate (BHB), a ketone body produced during KDs. Beyond being a fuel source, BHB helps shape gut microbial communities, reducing inflammation and harmful immune responses.Researchers demonstrated that supplementing bHB or transferring gut bacteria from KD-fed mice to others protected against disease. They also identified indole lactate, a metabolite produced by Lactobacillus bacteria influenced by bHB, as a critical factor in reducing inflammation. These findings suggest that targeting the gut microbiome and its metabolites could offer new strategies to manage autoimmune diseases, potentially offering alternatives to the strict dietary requirements of a KD.her clinical trials are needed, but the results so far are promising, paving the way for new, non-invasive treatment strategies for kidney diseases.